Analyst Ratings for Cara Therapeutics (CARA)

CARA Rating Summary

CARA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CARA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $24.83 (+66.3%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 85%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/3/2021 JPMorgan Jessica Fye New Coverage Neutral
(N/A)
16.00
(N/A)
11.97
(14.93)
24.73% Details
2/6/2019 Jefferies
» Updated 4/29/2021
Roger Song New Coverage Buy
(N/A)
23.00
(47.00)
15.37
(14.93)
-2.86% Details
Like CARA Ratings? Also take a look at SWKH, APH, MTSC, TTNP

CARA Ratings News